INS and endothelial dysfunction: Levels of blood glucose, insulin and HOMA-IR confirmed the effectiveness of SG also from this point of view, improving insulin resistance, reducing the consequential risk of endothelial dysfunction, atherogenic lipid profile, and new hypertension onset [18].